Dec. 11: Liver Cancer Therapies: Advancing the Frontiers of Transplant Oncology
October 27, 2026
Liver Cancer Therapies
Dec. 11, 9 a.m.-4:30 p.m.
MSTF Leadership Hall
This is a Continuing Medical Education (CME) Event.
At the conclusion of this activity, participants will be able to:
- Discuss the scope of the liver cancer program at the University of Maryland Medical Center and affiliated hospitals.
- Describe key directions in current liver cancer research.
- Identify new directions in treatments for liver cancer.
This conference is free; however, registration is required.
Accreditation
The University of Maryland School of Medicine (UMSOM) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UMSOM designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credits
AMA PRA Category 1 Credits (5.75 hours), Non-Physician Attendance (5.75 hours)
Activity Co-Directors: Kevin Kim, MD, MHS, and Daniel Maluf, MD